HomeACBM • OTCMKTS
add
ACRO Biomedical Co Ltd
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 115.10K | 1,163.99% |
Net income | -117.81K | -1,051.72% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 4.32K | 516.69% |
Total assets | 4.32K | -88.82% |
Total liabilities | 436.94K | 34.78% |
Total equity | -432.62K | — |
Shares outstanding | 60.04M | — |
Price to book | -0.07 | — |
Return on assets | -999.12% | — |
Return on capital | 295.92% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -117.81K | -1,051.72% |
Cash from operations | -54.41K | -758.88% |
Cash from investing | — | — |
Cash from financing | 58.71K | 860.83% |
Net change in cash | 4.30K | 2,009.78% |
Free cash flow | -12.94K | -257.32% |
About
Founded
2014
Headquarters
Website
